Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Journal of Cancer Research and Clinical Oncology
|
October 1, 2024
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)
David Witte, Ina Pretzell, Timm M Reissig, et al.
Liver Cancer
|
August 11, 2022
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
Sabrina Welland, Catherine Leyh, Fabian Finkelmeier, et al.
Gut
|
June 10, 2024
PARP-1 selectively impairs <i>KRAS</i>-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma
Friederike L Keggenhoff, Darko Castven, Diana Becker, et al.
International Journal of Cancer
|
June 24, 2026
A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients
Fabian Rose, Nada El-Ekiaby, Lilija Wehling, et al.
Cancers
|
March 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study
Christian Möhring, Moritz Berger, Farsaneh Sadeghlar, et al.
Hepatology Communications
|
November 4, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort
Tiago de Castro, Sabrina Welland, Leonie Jochheim, et al.
JHEP Reports : Innovation in Hepatology
|
February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study
Sabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Nature Reviews. Gastroenterology & Hepatology
|
February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Diego F Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews. Gastroenterology & Hepatology
|
December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Jesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Journal of Hepatology
|
February 15, 2022
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Laura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Journal of Cancer Research and Clinical Oncology
|
October 1, 2024
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)
David Witte, Ina Pretzell, Timm M Reissig, et al.
Liver Cancer
|
August 11, 2022
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
Sabrina Welland, Catherine Leyh, Fabian Finkelmeier, et al.
Gut
|
June 10, 2024
PARP-1 selectively impairs <i>KRAS</i>-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma
Friederike L Keggenhoff, Darko Castven, Diana Becker, et al.
International Journal of Cancer
|
June 24, 2026
A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients
Fabian Rose, Nada El-Ekiaby, Lilija Wehling, et al.
Cancers
|
March 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study
Christian Möhring, Moritz Berger, Farsaneh Sadeghlar, et al.
Hepatology Communications
|
November 4, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort
Tiago de Castro, Sabrina Welland, Leonie Jochheim, et al.
JHEP Reports : Innovation in Hepatology
|
February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study
Sabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Nature Reviews. Gastroenterology & Hepatology
|
February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Diego F Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews. Gastroenterology & Hepatology
|
December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Jesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Journal of Hepatology
|
February 15, 2022
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Laura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, et al.
Page
of 8